Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Regencell Bioscience Holdings Ltd RGC

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.


NDAQ:RGC - Post by User

User Avatar Image
(0)
•••
  • sungrin1309X
Post by sungrin1309on Oct 21, 2022 10:35am
100 Views
Post# 35038717

RGC: Another counter in eyes of Short Sellers. Short Squeeze

RGC: Another counter in eyes of Short Sellers. Short SqueezeRGC: Another counter in eyes of Short Sellers. Short Squeezers to Arms!

Short sellers have their sights set on Regencell (Nasdaq: RGC).

After taking the company IPO last year on July 2021, RGC became a victim for short-sellers where intraday volume often as high as 40% - 90% are recorded on certain days. According to the SEC, this coordinated pattern could be an indication of a possible “naked short” which took place strategically.

In comparison of numbers, RGC’s total reported cumulative short volume is > 19 million shares while its total reported short volume to outstanding shares ratio (excluding CEO and Chairman ownership) is 7.63x. RGC is more heavily shorted than GME (in fact almost double)
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities